HeartSciences, a company specializing in AI-driven medical technology, has announced that its MyoVista® wavECG™ has been honored by the Innovation Value Institute (IVI) for its potential to significantly advance healthcare.

The MyoVista wavECG will be featured at the 4th Digital Health Symposium, which will take place at the United Nations General Assembly in New York, USA, in September 2024.

Established in 2006, the IVI is a research institute at Maynooth University, Ireland, focusing on digital transformation and technology adoption.

This recognition comes after HeartSciences showcased the MyoVista wavECG at IVI’s International Digital Health Summer School 2024, an event centered on AI in health and electronic health records, attended by international representatives from health systems, governments, and industry.

"Global healthcare challenges, we need more than incremental improvements. We need technologies that offer transformative, 10X enhancements, shifting from emergency and elective care to preventive and proactive solutions.

The MyoVista wavECG represents such a breakthrough, demonstrating its potential for early disease detection in frontline healthcare settings.”

"The MyoVista wavECG has been acknowledged as a transformative technology in healthcare. We look forward to presenting our innovation at the United Nations General Assembly Digital Health Symposium in September."

"This recognition highlights our recent achievements, including gaining support from key opinion leaders and expanding our reach in the UK and Ireland, and underscores the significant commercial potential of our AI-ECG products.”






Source: globenewswire.com

Report Abuse